Literature DB >> 18325130

Neuroborreliosis in the South West of England.

J K Lovett1, P H Evans, S O'Connell, N J Gutowski.   

Abstract

Although Lyme borreliosis is increasingly diagnosed in the United Kingdom, few systematic studies have been performed there. UK data suggest that the commonest complications are neurological, but inadequate information exists about their nature and the incidence of late neuroborreliosis. Local data are necessary because clinical presentations may show geographical variation. This study aimed to provide data on clinical manifestations in an area of South West England and to estimate treatment delay. We reviewed clinical records of 88 patients in the Royal Devon and Exeter Hospital catchment area who had positive Borrelia antibody tests during a 5-year period. Fifty-six (64%) reported tick bites. The commonest presentations were erythema migrans (65%) and arthralgia/myalgia (27%). However, 22 patients (25%) had neurological symptoms other than headache alone. Fourteen had facial palsy, eight had confusion/drowsiness, four had meningism, five had radiculopathy, two had sixth nerve palsies, and two had peripheral neuropathies. No late, progressive or atypical neurological syndromes were found. Neurological manifestations were generally predictable and usually included either (or all) of meningoencephalitis, facial palsy or radiculopathy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18325130      PMCID: PMC2870777          DOI: 10.1017/S0950268808000472

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  10 in total

Review 1.  Misconceptions about Lyme disease: confusions hiding behind ill-chosen terminology.

Authors:  Leonard H Sigal
Journal:  Ann Intern Med       Date:  2002-03-05       Impact factor: 25.391

2.  European Concerted Action on Lyme Borreliosis (EUCALB).

Authors:  S O Connell
Journal:  Euro Surveill       Date:  1996-03

3.  The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.

Authors:  Gary P Wormser; Raymond J Dattwyler; Eugene D Shapiro; John J Halperin; Allen C Steere; Mark S Klempner; Peter J Krause; Johan S Bakken; Franc Strle; Gerold Stanek; Linda Bockenstedt; Durland Fish; J Stephen Dumler; Robert B Nadelman
Journal:  Clin Infect Dis       Date:  2006-10-02       Impact factor: 9.079

4.  Evaluation of study patients with Lyme disease, 10-20-year follow-up.

Authors:  R A Kalish; R F Kaplan; E Taylor; L Jones-Woodward; K Workman; A C Steere
Journal:  J Infect Dis       Date:  2000-12-27       Impact factor: 5.226

5.  Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease.

Authors:  M S Klempner; L T Hu; J Evans; C H Schmid; G M Johnson; R P Trevino; D Norton; L Levy; D Wall; J McCall; M Kosinski; A Weinstein
Journal:  N Engl J Med       Date:  2001-07-12       Impact factor: 91.245

6.  The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985-1990. A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production.

Authors:  K Hansen; A M Lebech
Journal:  Brain       Date:  1992-04       Impact factor: 13.501

7.  Lyme disease surveillance in England and Wales, 1986 1998.

Authors:  R Smith; S O'Connell; S Palmer
Journal:  Emerg Infect Dis       Date:  2000 Jul-Aug       Impact factor: 6.883

8.  The neurological complications of Borrelia burgdorferi in the New Forest area of Hampshire.

Authors:  D E Bateman; N F Lawton; J E White; R J Greenwood; D J Wright
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-05       Impact factor: 10.154

Review 9.  Clinical aspects of neuroborreliosis and post-Lyme disease syndrome in adult patients.

Authors:  Hans-Walter Pfister; Tobias A Rupprecht
Journal:  Int J Med Microbiol       Date:  2006-03-09       Impact factor: 3.473

10.  An epidemiologic study of Lyme disease in southern Sweden.

Authors:  J Berglund; R Eitrem; K Ornstein; A Lindberg; A Ringér; H Elmrud; M Carlsson; A Runehagen; C Svanborg; R Norrby
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245

  10 in total
  6 in total

1.  Lyme disease in the U.K.: clinical and laboratory features and response to treatment.

Authors:  Richard Dillon; Susan O'Connell; Stephen Wright
Journal:  Clin Med (Lond)       Date:  2010-10       Impact factor: 2.659

2.  Neuroborreliosis: the Guillain-Barré mimicker.

Authors:  Niharika Tyagi; Tim Maheswaran; Sunil Wimalaratna
Journal:  BMJ Case Rep       Date:  2015-06-25

3.  Borrelia burgdorferi, a great chameleon: know it to recognize it!

Authors:  Iolanda Santino; Paola Comite; Giuseppe Maria Gandolfo
Journal:  Neurol Sci       Date:  2009-11-06       Impact factor: 3.307

4.  Characteristics and patient pathways of Lyme disease patients: a retrospective analysis of hospital episode data in England and Wales (1998-2015).

Authors:  John S P Tulloch; Valerie Decraene; Rob M Christley; Alan D Radford; Jenny C Warner; Roberto Vivancos
Journal:  BMC Public Health       Date:  2019-08-15       Impact factor: 3.295

5.  Experience of Lyme disease and preferences for precautions: a cross-sectional survey of UK patients.

Authors:  Afrodita Marcu; Julie Barnett; David Uzzell; Konstantina Vasileiou; Susan O'Connell
Journal:  BMC Public Health       Date:  2013-05-16       Impact factor: 3.295

6.  Confirmed cases of Neuroborreliosis with involvement of peripheral nervous system: Description of a cohort.

Authors:  Anne-Laure Kaminsky; Thierry Maisonobe; Timothée Lenglet; Dimitri Psimaras; Rabab Debs; Karine Viala
Journal:  Medicine (Baltimore)       Date:  2020-10-02       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.